Research Article

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study

Table 3

Procedural data.

Procedural data

Lesion prestenosis (%)
 <50%, n2 (2.1)
 50–70%, n7 (7.5)
 >70%, n76 (80.9)
 100%, n9 (9.6)
Pre-TIMI 3flow, n (%)71 (75.5)
Post-TIMI 3flow, n (%)93 (98.9)

Interventional stage (%)
 Pretreatment, n (%)3 (3.2)
 Primary, n (%)80 (85.1)
 Adjunct, n (%)7 (7.4)
 Missing, n (%)4 (4.3)

Target vessel (%)
 Cx, n (%)21 (22.3)
 LAD, n (%)25 (26.6)
 LMS, n (%)6 (6.4)
 RCA, n (%)32 (34)
 SVG, n (%)10 (10.6)
ATM pressure in mmHg, mean (sd)65.5 (9.7)
ATM pressure in mmHg, median (IQR)66 (59, 72)

Number of vessel PCI
 1 vessel PCI, n (%)81 (86.2)
 2 vessel PCI, n (%)12 (12.8)
 3 vessel PCI, n (%)1 (1.1)
Bifurcation, n (%)13 (13.8)
GP iiB/iiiA use, n (%)2 (2.1)
Bivalirudin use, n (%)23 (24.5)
OCT/IVUS, n (%)19 (20.2)
Angiographic failure, n (%)2 (2.1)
Angiographic success, n (%)92 (97.9)
Number of lesions, mean (sd)1.2 (0.5)
Number of lesions, median (IQR)1 (1, 1)

Number of lesions (%)
 1 n, (%)82 (87.2)
 ≥2 n, (%)12 (12.8)
Length of balloon in mm, mean (sd)22.2 (9.2)
Length of balloon in mm, median (IQR)20 (15, 25)